COMMUNIQUÉS West-GlobeNewswire
-
NÉOVACS ANNONCE LA POURSUITE DU DÉVELOPPEMENT DE L'IFNalpha KINOIDE EN CORÉE DU SUD, AVEC SON PARTENAIRE CHONG KUN DANG (CKD) PHARMACEUTICAL
11/10/2018 - 07:01 -
Fagron continues strong turnover growth of first semester in the third quarter of 2018
11/10/2018 - 07:01 -
TearLab Update on 510(k) for U.S. FDA Clearance of Discovery™ MMP-9 Test
11/10/2018 - 00:00 -
Veloxis to Present at Jefferies 2018 London Healthcare Conference
10/10/2018 - 23:13 -
B. Braun Successfully Integrates with Cerner at McLaren Hospital
10/10/2018 - 22:48 -
K2M Receives FDA Clearance Including Surgical Guidance that Enhances MESA® Platform Using Patient-Specific Rods & Rails
10/10/2018 - 22:35 -
Novartis announces new data from the first direct head-to-head trial to demonstrate superior efficacy of Gilenya® over Copaxone® in patients with relapsing remitting multiple sclerosis
10/10/2018 - 22:31 -
Constellation Pharmaceuticals Enhances and Expands Phase 2 MANIFEST Study of CPI-0610 in Myelofibrosis
10/10/2018 - 22:30 -
Evidence on the Safety and Efficacy of Ortho-R in a Large Animal Model Presented at 2018 SICOT World Congress
10/10/2018 - 22:30 -
SeaSpine Commences Public Offering of Common Stock
10/10/2018 - 22:24 -
Loop Industries Reports Second Quarter of Fiscal 2019 Consolidated Results
10/10/2018 - 22:15 -
Conformis to Host Third Quarter 2018 Financial Results Webcast on October 31, 2018
10/10/2018 - 22:10 -
Histogenics Corporation Announces Closing of Public Offering of Common Stock and Warrants
10/10/2018 - 22:01 -
CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease
10/10/2018 - 22:01 -
JDRF celebrates Health Canada’s new licence for technology that will improve the lives of people with type 1 diabetes
10/10/2018 - 20:56 -
SuperSonic Imagine will present its new ultrasound platform, the Aixplorer MACH 30, at the French Radiology Days (JFR) from October 12 - 15 in Paris
10/10/2018 - 19:00 -
bioAffinity Licenses CyPath® Lung to Precision Pathology Services
10/10/2018 - 18:00 -
OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Submission of Investigational New Drug Application to Evaluate Tedopi® in Combination with Nivolumab in Pancreatic Cancer
10/10/2018 - 18:00 -
LE GROUPE EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
10/10/2018 - 17:46
Pages